Bibliography
- Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma(ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63:8-160
- Bousquet J, Khaltaev N, Cruz A, et al. ARIA Update: In collaboration with GA2LEN and AllerGen. 2007. Available from: http://www.whiar.org/docs/ARIA_WR_wm.pdf [13-2-2008]
- Ciprandi G, Passalacqua G. Emerging anti-inflammatory agents for allergic rhinitis. Expert Opin Emerging Drugs 2005;10:689-705
- Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62(85 Suppl):17-25
- Ciprandi G, Cirillo I, Vizzaccaro A, et al. Seasonal and perennial allergic rhinitis: is this classification adherent to real life? Allergy 2005;60:882-7
- Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-334
- Riedi CA, Rosario NA, Ribas LF, et al. Increase in prevalence of rhinoconjunctivitis but not asthma and atopic eczema in teenagers. J Investig Allergol Clin Immunol 2005;15:183-8
- Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478-518
- Task Force on Allergic Disorders. The Allergy Report. Volume 1. 2000. Milwaukee, WI, American Academy of Allergy, Asthma and Immunology. Available from: http://www.theallergyreport.com
- Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-9
- Naclerio R. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg 2008;138:129-39
- Blaiss MS. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids. Curr Med Res Opin 2008;24:821-36
- Salter M, Biggadike K, Matthews JL, et al. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 2007;293:L660-7
- Miri S, Farid R, Akbari H, et al. Prevalence of allergic rhinitis and nasal smear eosinophilia in 11- to 15 yr-old children in Shiraz. Pediatr Allergy Immunol 2006;17:519-23
- Moller C, Ahlstrom H, Henricson KA, et al. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clin Exp Allergy 2003;33:816-22
- Fokkens WJ, Jogi R, Reinartz S, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007;62:1078-84
- Kaiser HB, Naclerio RM, Given J, et al. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2007;119:1430-7
- Martin BG, Ratner PH, Hampel FC, et al. Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc 2007;28:216-25
- Bielory L, Katelaris CH, Lightman S, et al. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. MedGenMed 2007;9:35
- Munk ZM, Gross GN, Hampel FC Jr, et al. Preseasonal, once daily triamcinolone acetonide nasal aerosol for seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;78:325-31
- Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994;24:1144-50
- Meltzer EO, Jalowayski AA, Orgel HA, et al. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol 1998;102:39-49
- Schenkel E, LaForce C, Gates D. Mometasone furoate nasal spray in seasonal allergic rhinitis – effective in relieving ocular symptoms. Allergy Clin Immunol Int 2007;19:50-3
- Bielory L, Danzig M, Gates D. Ocular symptoms of seasonal allergic rhinitis can be treated effectively with an inhaled corticosteroid (mometasone furoate nasal spray). J Allergy Clin Immunol 2007;119:S61
- DeWester J, Philpot EE, Westlund RE, et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 2003;24:331-7
- Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7
- Baroody FM, Foster KA, Markaryan A, et al. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2008;100:194-9
- Baroody FM, Shenaq D, deTineo M, et al. Intranasal fluticasone furoate (FF) reduces eye symptoms after nasal allergen challenge (NAC). J Allergy Clin Immunol 2008;121:S151
- Valotis A, Högger P. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir Res 2007;8:54
- Allen A, Down G, Newland A, et al. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Clin Ther 2007;29:1415-20
- Rosenblut A, Bardin PG, Muller B, et al. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 2007;62:1071-7
- Lam DS, Fan DS, Ng JS, et al. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial. Clin Exp Ophthalmol 2005;33:252-8
- Naclerio RM, Pinto J, deTineo M, et al. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc 2008;29:24-8
- Denburg JA, Keith PK. Systemic aspects of chronic rhinosinusitis. Immunol Allergy Clin North Am 2004;24:87-102
- Grossman J. One airway, one disease. Chest 1997;111:S11-6